Search details
1.
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Lancet Oncol
; 24(1): 64-76, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36528035
2.
Neoplastic bone marrow invasion:rapid exclusion of hematological disease by flow cytometric routine panels.
Blood Cells Mol Dis
; 99: 102721, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36459839
3.
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient.
Acta Haematol
; 146(5): 408-412, 2023.
Article
in English
| MEDLINE | ID: mdl-37231772
4.
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 22(12): 1705-1720, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34774221
5.
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.
Blood
; 134(12): 935-945, 2019 09 19.
Article
in English
| MEDLINE | ID: mdl-31395600
6.
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia.
Haematologica
; 106(9): 2345-2353, 2021 09 01.
Article
in English
| MEDLINE | ID: mdl-32732360
7.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Haematologica
; 106(6): 1559-1568, 2021 06 01.
Article
in English
| MEDLINE | ID: mdl-32467145
8.
Durable Molecular Remission in an Elderly Patient Affected by Relapsed Ph'+ Acute Lymphoblastic Leukemia with T315I and Concomitant p190 and p210 Expression Achieved by Inotuzumab and Ponatinib.
Chemotherapy
; 66(3): 78-81, 2021.
Article
in English
| MEDLINE | ID: mdl-34102636
9.
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies.
Biol Blood Marrow Transplant
; 26(6): 1113-1118, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32068095
10.
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment.
Hematol Oncol
; 38(2): 189-196, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-31891213
11.
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions.
Support Care Cancer
; 27(3): 793-803, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30564934
12.
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.
Blood
; 124(19): 2930-6, 2014 Nov 06.
Article
in English
| MEDLINE | ID: mdl-25232059
13.
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
Haematologica
; 101(1): 77-85, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26565002
14.
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.
Haematologica
; 101(12): 1544-1552, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27515250
15.
Primitive "Spindle Cell Variant" (Sarcomatoid Variant) Diffuse Large B-Cell Lymphoma of the Uterine Cervix: Description and Outcome of a Rare Case.
Int J Gynecol Pathol
; 35(6): 593-597, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27167673
16.
New landscapes in the management of myelodysplastic syndromes and chronic myelomonocytic leukemia: oral decitabine.
Future Oncol
; 17(16): 1973-1975, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33878941
17.
SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies.
Br J Haematol
; 190(1): e5-e8, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32369605
18.
Caring for terminal patients in haematology: the urgent need of a new research agenda.
Support Care Cancer
; 23(1): 5-7, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25341550
19.
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(10): 1612-7, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24953019
20.
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment.
Ann Hematol
; 93(10): 1765-74, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24923451